Submit a comment
Citation Information: J Clin Invest. 1991;87(4):1312-1321. https://doi.org/10.1172/JCI115134.
Abstract
Expression of IL-1 alpha and beta genes was studied in human blood PMN with close monitoring of the effects of contaminating mononuclear leukocytes (MNL). We provide evidence that PMN both transcribe and translate IL-1 alpha and beta genes after stimulation with LPS or IL-1 alpha. A combination of mouse thymocyte comitogen proliferation assay, ELISA, and immunocytochemistry was required to establish that IL-1 alpha and beta synthesis observed in preparations of PMN could not be accounted for by the low level of contaminating MNL. Synthesis of IL-1 beta in PMN exceeded that of IL-1 alpha, but little or no IL-1 alpha was released by PMN. Although increases in IL-1 mRNA after stimulation of PMN and MNL with LPS were similar, PMN were less efficient than MNL in translating IL-1 mRNA. In contrast, PMN and MNL IL-1 alpha and beta mRNAs were translated with equal efficiency in rabbit reticulocyte lysates, suggesting that synthesis of IL-1 in PMN is subject to some form of translational control. We conclude that PMN stimulated with LPS efficiently transcribe but inefficiently translate IL-1 genes relative to MNL. IL-1 beta transcription and translation predominates over that of IL-1 alpha, and IL-1 beta is the predominant IL-1 protein released by PMN. IL-1 can induce its own synthesis in PMN.
Authors
P C Lord, L M Wilmoth, S B Mizel, C E McCall
Guidelines
The Editorial Board will only consider comments that are deemed relevant and of interest to readers. The Journal will not post data that have not been subjected to peer review; or a comment that is essentially a reiteration of another comment.
- Comments appear on the Journal’s website and are linked from the original article’s web page.
- Authors are notified by email if their comments are posted.
- The Journal reserves the right to edit comments for length and clarity.
- No appeals will be considered.
- Comments are not indexed in PubMed.
Specific requirements
- Maximum length, 400 words
- Entered as plain text or HTML
- Author’s name and email address, to be posted with the comment
- Declaration of all potential conflicts of interest (even if these are not ultimately posted); see the Journal’s conflict-of-interest policy
- Comments may not include figures
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)